MarketInOut Stock Screener Log In | Sign Up
 

Standard BioTools Inc

NASDAQ • Healthcare • Medical Devices • Quote as of 10/23/2026
Standard BioTools Inc stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization249.52 mln
Float377 mln
Earnings Date11/10/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

4.24
Highly suspicious

Relative Strength

21 / 100
Significantly lagging

Debt / Equity

0.05
Debt-free

Pre-Tax Margin

-108%
Severely loss-making

ROE

-18.60
Negative

Business Description

Standard BioTools Inc. is a Boston-based company that makes instruments, consumables, and related services for scientists working to advance medicine and healthcare. Its two main areas of focus are proteomics and genomics, offering tools that help researchers study proteins, genes, and tissue at a highly detailed level. The company serves a broad range of customers, from universities and cancer centers to biotech and pharmaceutical companies, across the Americas, Europe, the Middle East, Africa, and the Asia-Pacific region. Formerly known as Fluidigm Corporation, the company has been operating since 1999 and holds licensing agreements with several leading research institutions.

Key Fundamentals

EPS-0.13
ROE-18.60
RPS0.22
ROIC-14.44
ROA-14.91
Interest Cover-5,346
EBITDA, mln-85.40
EV / EBITDA1.88
EV / EBIT1.76
Revenue, mln84.60

Quote Details

Last 0.6056
Change -0.03 (-4.72%)
Open 0.634
Volume 852,637
Turnover 516,357
Average Volume 840,853

Financial Ratios

Pre-Tax Profit Margin-108
Leverage Ratio1.16
Current Ratio9.10
Price / Book0.53
Price / Tangible Book0.53
Debt / Equity0.05
Price / Sales3.37

Financial Strength

Altman Z-Score-0.13
Piotroski F-Score 4 / 9
Beneish M-Score4.24
Short Ratio1.83
Short % of Float1.06

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -3.72% 20 / 100   
1 Month -18.49% 19 / 100   
2 Months -28.75% 17 / 100   
6 Months -32.67% 20 / 100   
1 Year -54.12% 17 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog